These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9554803)

  • 1. SR142948A is a potent antagonist of the cardiovascular effects of neurotensin.
    Schaeffer P; Laplace MC; Bernat A; Prabonnaud V; Gully D; Lespy L; Herbert JM
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):545-50. PubMed ID: 9554803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neurotensin receptor antagonism on latent inhibition in Sprague-Dawley rats.
    Binder EB; Gross RE; Nemeroff CB; Kilts CD
    Psychopharmacology (Berl); 2002 May; 161(3):288-95. PubMed ID: 12021832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin induces the release of prostacyclin from human umbilical vein endothelial cells in vitro and increases plasma prostacyclin levels in the rat.
    Schaeffer P; Laplace MC; Prabonnaud V; Bernat A; Gully D; Lespy L; Herbert JM
    Eur J Pharmacol; 1997 Apr; 323(2-3):215-21. PubMed ID: 9128841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
    Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro.
    Pinnock RD; Woodruff GN
    Neurosci Lett; 1994 May; 172(1-2):175-8. PubMed ID: 8084529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats.
    Karinch AM; Schmidt GL; Kauffman GL
    Brain Res; 1998 Nov; 810(1-2):123-9. PubMed ID: 9813278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
    Gully D; Lespy L; Canton M; Rostène W; Kitabgi P; Le Fur G; Maffrand JP
    Life Sci; 1996; 58(8):665-74. PubMed ID: 8594316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.
    Oury-Donat F; Thurneyssen O; Gonalons N; Forgez P; Gully D; Le Fur G; Soubrie P
    Br J Pharmacol; 1995 Sep; 116(2):1899-905. PubMed ID: 8528577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of diphenhydramine and SR142948A on periaqueductal gray neurons and on the interactions between the medial preoptic nucleus and the periaqueductal gray.
    Kreitel KD; Swisher CB; Behbehani MM
    Neuroscience; 2002; 114(4):935-43. PubMed ID: 12379249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin phase-shifts the firing rate rhythm of neurons in the rat suprachiasmatic nuclei in vitro.
    Meyer-Spasche A; Reed HE; Piggins HD
    Eur J Neurosci; 2002 Jul; 16(2):339-44. PubMed ID: 12169114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
    Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
    J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
    Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
    Cáceda R; Binder EB; Kinkead B; Nemeroff CB
    Schizophr Res; 2012 Apr; 136(1-3):88-95. PubMed ID: 22104138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin excitation of serotonergic neurons in the rat nucleus raphe magnus: ionic and molecular mechanisms.
    Li AH; Yeh TH; Tan PP; Hwang HM; Wang HL
    Neuropharmacology; 2001 Jun; 40(8):1073-83. PubMed ID: 11406199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Townsend CM
    Surg Oncol; 1996; 5(5-6):245-51. PubMed ID: 9129137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: evidence for the involvement of multiple receptors.
    Trudeau LE
    Neuroscience; 2000; 97(2):293-302. PubMed ID: 10799761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice.
    Marie-Claire C; Palminteri S; Romualdi P; Noble F
    Neuropharmacology; 2008 Jun; 54(7):1107-11. PubMed ID: 18410947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity.
    Rowe WB; Nicot A; Sharma S; Gully D; Walker CD; Rostène WH; Meaney MJ; Quirion R
    Neuroendocrinology; 1997 Aug; 66(2):75-85. PubMed ID: 9263204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task.
    Azmi N; Norman C; Spicer CH; Bennett GW
    Behav Pharmacol; 2006 Jun; 17(4):357-62. PubMed ID: 16914954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
    Díaz-Cabiale Z; Fuxe K; Narváez JA; Finetti S; Antonelli T; Tanganelli S; Ferraro L
    Neuroreport; 2002 May; 13(6):763-6. PubMed ID: 11997683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.